Beta Bionics, Inc. Insider Selling: Mark Hopman Trims Stake

A Form 4 filed with the SEC shows Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc. (BBNX), sold 35,994 shares of company stock on 2026-09-09.

The transaction was executed at a price of $18.46 per share, for a total value of approximately $664,550.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.